Loading...
CRH PLC is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial growth and has positive long-term analyst ratings, the recent price decline, lack of strong trading signals, and mixed sentiment in options data suggest waiting for a better entry point.
The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral at 40.649, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its key support level (S1: 121.563), indicating potential downside risk.

Hedge funds are significantly increasing their positions (+168.58% last quarter).
Strong financial performance in Q3 2025, with revenue, net income, and EPS all showing growth.
Analysts maintain long-term positive ratings with price targets as high as $160.
Recent price decline (-3.90% in regular market, -0.60% post-market).
No recent news or event-driven catalysts to support a rebound.
Mixed analyst sentiment with some price target reductions (e.g., Wells Fargo lowered target to $133).
In Q3 2025, CRH reported a revenue increase of 5.27% YoY to $11.07B, net income growth of 9.23% YoY to $1.503B, and EPS growth of 10.95% YoY to $2.23. Gross margin also improved slightly to 38.93%, up 0.85% YoY.
Analysts are generally positive on CRH, with recent price targets ranging from $133 to $160. UBS and Citi have reiterated Buy ratings with higher price targets, while Wells Fargo remains neutral with an Equal Weight rating.